Zydus Lifesciences Limited (Zydus) signed contracts with PAI and two Amplitude Surgical minority shareholders to purchase blocks of shares, which together account for 85.6% of Amplitude Surgical's voting rights and share capital, for €6.25 per share
The 11th International Exhibition and Healthcare will take place at Bharat Mandapam in New Delhi on September 4–6, 2025. This flagship event, which is organized by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) with assistance
On the occasion of Lung Cancer Day, renowned oncosurgeon Prof Dr Raj Nagarkar, MD & Chief of Surgical Oncology and Robotic Services at HCG Manavata Cancer Centre, Nashik, has urged for urgent public attention to the rising incidence of lung cancer...
Maxivision Super Speciality Eye Hospitals (‘Maxivision’), one of India's fastest-growing eye care providers, announced its strategic expansion in Chennai with the launch of 10 eye hospitals/vision centres across Chennai...
In a significant move toward the Indian pharmaceutical industry, Procter and Gamble (P&G) would invest over Rs 2,000 crore in Gujarat to have a state of the art manufacturing facility of psyllium husk based-Laxative drugs...
The Government of Karnataka state has made a formal notification to merge the AYUSH Drug Licensing Authority, Drug Enforcement Division, and Drug Testing Laboratories in the State Food and Drug Administration
Iberia Pharmaceuticals is establishing a modern skincare manufacturing and research plant in Jhajjar Haryana, a significant first step to enhance its presence in India in the skincare sector. The modern unit will include 60,000 sq. ft. and...
In Nobeoka City, Miyazaki, Japan, Asahi Kasei Life Science, a branch of the multifaceted international manufacturer Asahi Kasei, revealed intentions to build a new spinning mill for its Planova virus elimination filters
In a momentous advancement for lung cancer care in Ghana, AstraZeneca and Revna Biosciences have renewed their commitment to improve access to diagnosis and treatment. Building on a strategic initiative announced in April 2025, this undertaking...
Hyderabad pharmaceutical company Aurobindo Pharma said on July 30 that its US-based unit, Aurobindo Pharma USA Inc., has signed a binding agreement to buy Lannett Company LLC